Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 17 de 17
Filter
Add more filters










Publication year range
1.
Int J Pharm X ; 4: 100128, 2022 Dec.
Article in English | MEDLINE | ID: mdl-36204592

ABSTRACT

NFL-TBS.40-63 peptide is a recently discovered peptide derived from the light neurofilament chain (NFL). In this study, we demonstrated that the Biotinylated-NFL-peptide (BIOT-NFL) can spontaneously self-assemble into well-organized nanofibers (approximately 5 nm width and several micrometers in length) in several solutions, whereas the typical self-assembly was not systematically observed from other peptides with or without coupling. The critical aggregation concentration that allows the BIOT-NFL-peptide to aggregate and auto associate was determined at 10-4 mol/L by surface tension measurements. X-ray scattering of BIOT-NFL-peptide also demonstrated its beta-sheet structure that can facilitate the intermolecular interactions involved in the self-assembly process. The possible disassembly of self-assembled BIOT-NFL-peptide-nanofibers was examined via a dialysis membrane study. We further investigated the interaction between nanofibers formed by BIOT-NFL-peptide and gold nanoparticles. Interestingly, a strong interaction was demonstrated between these nanoparticles and BIOT-NFL-peptide resulted in the formation of BIOT-NFL-peptide-nanofibers grandly decorated by gold nanoparticles. Finally, we investigated the internalization of gold nanoparticles coupled with BIOT-NFL-nanofibers into F98 rat glioblastoma cells, which was increased compared to the non-coupled control gold nanoparticles. All these results indicate that this peptide could be a promising therapeutic agent for targeted delivery.

2.
Int J Pharm X ; 4: 100127, 2022 Dec.
Article in English | MEDLINE | ID: mdl-36177093

ABSTRACT

Several studies previously showed that the NFL-TBS.40-63 peptide (NFL-peptide) is capable to specifically penetrating several glioblastoma cell lines (rat, mouse, human) and inhibiting their cell division in vitro and their tumor development in vivo. When lipid nanocapsules (LNCs) are functionalized with the NFL-peptide, their absorption is targeted in glioblastoma cells both in vitro and in vivo. In the present study, we investigated the molecular architecture of these nanovectors (LNC-NFL) by using several microscopy techniques (transmission electron microscopy, cryo-electron microscopy, and cryo-electron tomography). We also used high-performance liquid chromatography (UPLC) technique to evaluate the interaction between LNCs and peptides. The work shows that the NFL-peptide forms stable long filaments along which the lipid nanocapsules interact strongly to form some sort of nanomolecular bracelets. This new construction composed of the NFL-peptide and lipid nanocapsules shows a better internalization in rat glioblastoma cells (F98 cells) than lipid nanocapsules alone.

3.
Int J Pharm X ; 4: 100129, 2022 Dec.
Article in English | MEDLINE | ID: mdl-36164551

ABSTRACT

Targeting, detecting, and destroying selectively cancer cells or specific organelles is a major challenge of nanomedicine. Recently, a new methodology was conceived to synthesize gold nanoparticles combined with a peptide having a C-terminal biotin (BIOT-NFL-peptide). This methodology called "Method IN" allows specific interactions between the BIOT-NFL-peptide, the polyethylene glycol diacid (PEG-COOH) and the gold salt (Au III) to produce multifunctional hybrid nano-carriers called BIOT-NFL-PEG-AuNPs. Here, we show that it is possible to use this strategy to synthesize multifunctional hybrid nano-carriers with other cell-penetrating peptides including TAT and Vim-peptides. Ex-vivo studies on F98 rat glioblastoma cells show that these new nanovectors acquire the cellular entry function of peptides and the gold particles make it possible to visualize by electron microscopy their localization in organelles. Thus, these new multifunctional nanovectors offer promising possibilities for the theranostic field, including the cell-penetrating property of the peptide, the intra-organelle localization of gold particles and their possible thermoplasmonic properties, as well as the stealth property of PEG.

4.
Oncogene ; 35(38): 5033-42, 2016 09 22.
Article in English | MEDLINE | ID: mdl-27041564

ABSTRACT

Little is known about the biological role of the phospholipase A2 receptor (PLA2R1) transmembrane protein. In recent years, PLA2R1 has been shown to have an important role in regulating tumor-suppressive responses via JAK2 activation, but the underlying mechanisms are largely undeciphered. In this study, we observed that PLA2R1 increases the mitochondrial content, judged by increased levels of numerous mitochondrial proteins, of the mitochondrial structural component cardiolipin, of the mitochondrial DNA content, and of the mitochondrial DNA replication and transcription factor TFAM. This effect of PLA2R1 relies on a transcriptional program controlled by the estrogen-related receptor alpha1 (ERRα) mitochondrial master regulator. Expression of ERRα and of its nucleus-encoded mitochondrial targets is upregulated upon PLA2R1 ectopic expression, and this effect is mediated by JAK2. Conversely, downregulation of PLA2R1 decreases the level of ERRα and of its nucleus-encoded mitochondrial targets. Finally, blocking the ERRα-controlled mitochondrial program largely inhibits the PLA2R1-induced tumor-suppressive response. Together, our data document ERRα and its mitochondrial program as downstream effectors of the PLA2R1-JAK2 pathway leading to oncosuppression.


Subject(s)
Janus Kinase 2/genetics , Neoplasms/genetics , Receptors, Estrogen/biosynthesis , Receptors, Phospholipase A2/genetics , Cell Line, Tumor , DNA-Binding Proteins/genetics , Gene Expression Regulation, Neoplastic , Genes, Tumor Suppressor , Humans , Mitochondria/genetics , Mitochondria/metabolism , Mitochondrial Proteins/genetics , Neoplasms/pathology , Receptors, Estrogen/genetics , Transcription Factors/genetics , Transcriptional Activation/genetics , ERRalpha Estrogen-Related Receptor
5.
Int J Pharm ; 454(2): 756-64, 2013 Oct 01.
Article in English | MEDLINE | ID: mdl-23769994

ABSTRACT

Plasmid DNA (pDNA) and small interfering RNAs (siRNAs) are very useful tools for the treatment of cancer. However, pDNA and siRNAs efficacy is restricted by their negative charge and susceptibility to degradation by endonucleases that prevent them penetrating tissue and cellular barriers such as the plasma and endolysosomal membranes. Viral vectors have some advantages but their use is largely limited by their immunogenicity. On the other hand, synthetic nanoparticles have advantage of being relatively non-immunogenic but their ability to deliver nucleic acids remains less efficient than their viral counterparts. The present study is focussed on the development and evaluation of biomimetic lipid nanocapsules (LNCs) functionalized with a L1 papillomavirus type-16 capsid-derived lipopeptide on their surface, for transfection of U87MG glioma cells and Caco-2 colorectal adenocarcinoma cells with pDNA or siRNAs. Since the L1-peptide has been described as a nuclear localization signal able to complex with nucleic acids and bind to heparan sulfate on the cell surface, the structure and function of L1-peptide bound to LNCs (L1-LNCs) were investigated. Although L1-LNCs were shown to complex with both pDNA and siRNAs, the pDNA-L1-LNC complexes showed only weak transfection efficiency. In contrast, siRNA-L1-LNC complexes appeared as effective repressors of targeted messengers.


Subject(s)
Capsid Proteins/chemistry , DNA/chemistry , Lipopeptides/chemistry , Nanocapsules/chemistry , Oncogene Proteins, Viral/chemistry , RNA, Small Interfering/chemistry , AC133 Antigen , Animals , Antigens, CD/genetics , COS Cells , Capsid Proteins/administration & dosage , Cell Line, Tumor , Chlorocebus aethiops , DNA/administration & dosage , Glycoproteins/genetics , Humans , Lipids/chemistry , Lipopeptides/administration & dosage , Nanocapsules/administration & dosage , Neoplasms/genetics , Neoplasms/metabolism , Oncogene Proteins, Viral/administration & dosage , Peptides/genetics , Plasmids , Proto-Oncogene Proteins c-bcl-2/genetics , RNA, Small Interfering/administration & dosage
6.
Int J Pharm ; 454(2): 765-74, 2013 Oct 01.
Article in English | MEDLINE | ID: mdl-23732394

ABSTRACT

The recent discovery of microRNA (miRNA) as major post-transcriptional repressors prompt the interest of developing novel approaches to target miRNA pathways to improve therapy. In this context, although the most significant barrier to their widespread clinical use remains delivery, nuclease-resistant locked nucleic acid (LNA) that bind specifically and irreversibly to miRNA represent interesting weapons. Thus, by focusing on oncongenic miR-21 miRNA, which participate to cancer cell resistance to apoptotic signals, the aim of the present study was to investigate the possibility of silencing miRNA by LNA conjugated to lipid nanocapsules (LNCs) as miRNA-targeted nanomedicines in U87MG glioblastoma (GBM) cells. After synthesis of an amphiphilic lipopeptide affine for nucleic acids, a post-insertion procedure during the LNC phase inversion formulation process allowed to construct peptide-conjugated LNCs. Peptide-conjugated LNCs were then incubated with LNAs to allow the formation of complexes characterized in gel retardation assays and by their physicochemical properties. U87MG cell treatment by LNA-LNC complexes resulted in a marked reduction of miR-21 expression as assessed by RTqPCR. In addition, exposure of U87MG cells to LNA-LNC complexes followed by external beam radiation demonstrated a significant improvement of cell sensitivity to treatment and emphasizes the interest to investigate further this miRNA-targeted strategy.


Subject(s)
Glioblastoma/genetics , Glioblastoma/radiotherapy , MicroRNAs/genetics , Nanocapsules/administration & dosage , Oligonucleotides/administration & dosage , Cell Death , Cell Line, Tumor , Humans , Lecithins/chemistry , Lipopeptides/chemistry , Nanocapsules/chemistry , Oligonucleotides/chemistry , Polyethylene Glycols/chemistry , RNA Interference , Stearic Acids/chemistry , Triglycerides/chemistry
7.
Int J Pharm ; 423(1): 93-101, 2012 Feb 14.
Article in English | MEDLINE | ID: mdl-21683129

ABSTRACT

In the context of targeted therapy, we addressed the possibility of developing a drug delivery nanocarrier capable to specifically reach cancer cells that express the most prominent marker associated with cancer stem cell (CSC) phenotype, AC133. For this purpose, 100nm lipid nanocapsules (LNCs) were functionalized with a monoclonal antibody (mAb) directed against AC133 according to two distinct methods: firstly, post-insertion within 100nm LNCs of a lipid poly(ethylene glycol) functionalized with reactive-sulfhydryl maleimide groups (DSPE-PEG(2000)-maleimide) followed by thiolated mAb coupling, and, secondly, creation of a thiolated lipo-immunoglobulin between DSPE-PEG(2000)-maleimide and AC133, then post-inserted within LNCs. Due to the reduced number of purification steps, lower amounts of DSPE-PEG(2000)-maleimide that were necessary as well as lower number of free maleimide functions present onto the surface of immuno-LNC, the second method was found to be more appropriate. Thus, 126nm AC133-LNC with a zeta potential of -22mV while keeping a narrow distribution were developed. Use of the IgG1κ isotype control-immunoglobulins produced similar control IgG1-LNCs. Micro-Bradford colorimetric assay indicated a fixation of about 40 immunoglobulins per LNC. Use of human Caco-2 cells that constitutively express AC133 (Caco-2-AC133(high)) allowed addressing the behavior of the newly functionalized immuno-LNCs. siRNA knockown strategy permitted to obtain Caco-2-AC133(low) for comparison. Immunofluorescence-combined flow cytometry analysis demonstrated that the epitope-recognition function of AC133 antibody was preserved when present on immuno-LNCs. Although grafting of immunoglobulins onto the surface of LNCs repressed their internalization within Caco-2 cells as evaluated by flow cytometry, AC133-specific cellular binding was obtained with AC133-LNC as assessed by computer-assisted fluorescence microscopy. In conclusion, interest of AC133-LNCs as niche carriers is discussed toward the development of CSC targeted chemo- or radio-nanomedicines.


Subject(s)
Antibodies, Monoclonal/immunology , Antigens, CD/immunology , Antigens, Neoplasm/immunology , Drug Delivery Systems/methods , Glycoproteins/immunology , Nanocapsules/chemistry , Nanoconjugates/chemistry , Peptides/immunology , AC133 Antigen , Antibodies, Monoclonal/chemistry , Antibodies, Monoclonal/metabolism , Antibodies, Monoclonal/pharmacology , Antigen-Antibody Reactions/immunology , Antigens, CD/genetics , Antigens, CD/metabolism , Antigens, Neoplasm/genetics , Antigens, Neoplasm/metabolism , Caco-2 Cells , Cell Adhesion/drug effects , Cell Membrane/metabolism , Cytoplasm/metabolism , Endocytosis/physiology , Glycoproteins/genetics , Glycoproteins/metabolism , Humans , Imidoesters/chemistry , Lecithins/chemistry , Maleimides/chemistry , Particle Size , Peptides/genetics , Peptides/metabolism , Phosphatidylethanolamines/chemistry , Polyethylene Glycols/chemistry , RNA, Small Interfering/genetics , Static Electricity , Stearic Acids/chemistry , Sulfhydryl Compounds/chemical synthesis , Surface Properties , Triglycerides/chemistry
8.
Cereb Cortex ; 22(2): 403-16, 2012 Feb.
Article in English | MEDLINE | ID: mdl-21666133

ABSTRACT

The relative contribution of intrinsic and extrinsic cues in the regulation of cortical neurogenesis remains a crucial challenge in developmental neurobiology. We previously reported that a transient population of glutamatergic neurons, the cortical plate (CP) transient neurons, migrates from the ventral pallium (VP) over long distances and participate in neocortical development. Here, we show that the genetic ablation of this population leads to a reduction in the number of cortical neurons especially fated to superficial layers. These defects result from precocious neurogenesis followed by a depletion of the progenitor pools. Notably, these changes progress from caudolateral to rostrodorsal pallial territories between E12.5 and E14.5 along the expected trajectory of the ablated cells. Conversely, we describe enhanced proliferation resulting in an increase in the number of cortical neurons in the Gsx2 mutants which present an expansion of the VP and a higher number of CP transient neurons migrating into the pallium. Our findings indicate that these neurons act to maintain the proliferative state of neocortical progenitors and delay differentiation during their migration from extraneocortical regions and, thus, participate in the extrinsic control of cortical neuronal numbers.


Subject(s)
Cell Movement/physiology , Cerebral Cortex , Glutamates/metabolism , Neural Stem Cells/physiology , Neurogenesis/genetics , Neurons/physiology , Age Factors , Animals , Animals, Newborn , Basic Helix-Loop-Helix Transcription Factors/genetics , Body Patterning/genetics , Bromodeoxyuridine/metabolism , Cadherins/metabolism , Cell Cycle/genetics , Cell Differentiation , Cell Movement/genetics , Cell Proliferation , Cerebral Cortex/cytology , Cerebral Cortex/embryology , Cerebral Cortex/growth & development , Cerebral Ventricles/cytology , Cerebral Ventricles/embryology , Cerebral Ventricles/growth & development , Embryo, Mammalian , Gene Expression Regulation, Developmental , Green Fluorescent Proteins/genetics , Homeodomain Proteins/genetics , Homeodomain Proteins/metabolism , MEF2 Transcription Factors , Mice , Mice, Inbred C57BL , Mice, Transgenic , Mutation/genetics , Myogenic Regulatory Factors/metabolism , Nerve Tissue Proteins/genetics , Nerve Tissue Proteins/metabolism , Nuclear Proteins/metabolism , Nuclear Receptor Subfamily 2, Group C, Member 1/metabolism , Repressor Proteins/metabolism
11.
Leukemia ; 7(5): 733-5, 1993 May.
Article in English | MEDLINE | ID: mdl-8483326

ABSTRACT

The Kurloff cell (KC) of the guinea-pig develops natural killer cytotoxic activity in heterologous systems. We report in this paper the effective in vitro cytotoxic activity of the KC in a homologous guinea-pig system, i.e. against the guinea-pig target leukemic L2C cells. A dual-color flow analysis of homologous effector-target conjugates, using calcein-labeled KC and hydroethidine-labeled L2C shows a 40% frequency KC-L2C conjugation. The specific cytotoxicity of KC against L2C (78%) was estimated as the target-loss of green fluorescence due to hydrolysed carboxy-fluorescein diacetate after 4 hours at 37 degrees C. We propose that the Kurloff cell could be involved in surveillance against spontaneously arising leukemic cells, and this could be an explanation for the high degree of resistance to spontaneous or experimentally-induced cancers, in the guinea-pig.


Subject(s)
Cytotoxicity, Immunologic , Guinea Pigs/immunology , Killer Cells, Natural/immunology , Leukemia, Experimental/immunology , Animals , Flow Cytometry , Immunity, Cellular , In Vitro Techniques , Killer Cells, Natural/cytology , Lymph Nodes/cytology , Tumor Cells, Cultured
12.
Br J Haematol ; 83(4): 580-8, 1993 Apr.
Article in English | MEDLINE | ID: mdl-7686033

ABSTRACT

A small population of CD2 + CD19 + lymphoid cells have been suggested to be common lymphoid progenitors. CD2 + CD19 + biphenotypic ALL account for less than 2% of ALL. We analysed the clinical and laboratory features of a series of 16 patients with CD2 + CD19 + ALL. The incidence of tumoural syndrome was comparable to a previously published series of pre B-ALL but significantly different from that of T-ALL. The mean age of the 11 children of this series was 101 +/- 46 months, and differed significantly from that of children with pre B-ALL (P < 0.01). Complete remission was obtained for all patients except two adults. Only three relapses have been observed. Regardless of the presence of CD2 +, the 16 ALL could be classified as pre B-ALL, according to the nomenclature used by the GEIL. Nine samples could be analysed by Southern blotting. Seven had rearranged IGH genes, usually on both chromosomes. IGK rearrangement was observed in three cases. Only one case had rearranged both TCRG and TCR beta. The patterns observed here and those reported previously follow that of the pre B-ALL which confirms the engagement of most CD2 + CD19 + biphenotypic ALL in the B-lineage.


Subject(s)
Antigens, CD/analysis , Antigens, Differentiation, B-Lymphocyte/analysis , Antigens, Differentiation, T-Lymphocyte/analysis , Precursor Cell Lymphoblastic Leukemia-Lymphoma/immunology , Receptors, Immunologic/analysis , Adult , Antigens, CD19 , Blotting, Southern , CD2 Antigens , Child , Follow-Up Studies , Gene Rearrangement , Gene Rearrangement, T-Lymphocyte , Genes, Immunoglobulin , Humans , Immunophenotyping/methods , Precursor Cell Lymphoblastic Leukemia-Lymphoma/genetics
13.
Nat Immun Cell Growth Regul ; 10(6): 327-35, 1991.
Article in English | MEDLINE | ID: mdl-1787838

ABSTRACT

The relationship of the Kurloff cell (KC), guinea pig blood mononuclear cell with natural killer (NK) activity, to a known cell lineage was established. Using indirect immunoperoxidase staining and flow cytometric analysis, numerous monoclonal antibodies directed against guinea pig macrophage antigen, Ia antigen or different T lymphocyte markers and a polyclonal anti-IgM serum were tested in unimmunized estrogenized animals. We excluded any relationship between KC and the monocytic macrophage lineage (MR-1-) and between KC and the B lymphocyte lineage (CT10- and IgM-). The KC immunophenotype was pan T CT7 positive but 8BE6 (mature thymocyte) and CT6 (cytotoxic suppressor T lymphocyte) negative. Since KC displays an NK activity, this cell may be classified among the NK effector cells exhibiting some T lymphocyte markers.


Subject(s)
Killer Cells, Natural/immunology , T-Lymphocytes/immunology , Animals , Antibodies, Monoclonal , Antigens, Differentiation , Antigens, Differentiation, T-Lymphocyte , Estradiol/analogs & derivatives , Estradiol/pharmacology , Female , Guinea Pigs , Histocompatibility Antigens Class II , Immunoglobulin M/metabolism , Killer Cells, Natural/cytology , Killer Cells, Natural/drug effects , Male , Phenotype , T-Lymphocytes/cytology , T-Lymphocytes/drug effects
14.
Nouv Rev Fr Hematol (1978) ; 31(3): 209-16, 1989.
Article in English | MEDLINE | ID: mdl-2694093

ABSTRACT

Class II antigen expression on leukemic cells has been mainly studied using monoclonal antibodies (Mabs). On the other hand, class II polymorphism has been mainly studied using alloantisera. The present study shows that the reactivity of leukemic cells from different lineages with class II Mabs was not always the same as that obtained with alloantisera and that the reactivity varied depending on the leukemic cell-type studied.


Subject(s)
Histocompatibility Antigens Class II/analysis , Leukemia/immunology , Antibodies, Monoclonal , B-Lymphocytes , Burkitt Lymphoma/immunology , Fluorescent Antibody Technique , HLA-DQ Antigens/analysis , HLA-DR Antigens/analysis , Humans , Immunoassay , Isoantibodies , Leukemia, Hairy Cell/immunology , Leukemia, Lymphocytic, Chronic, B-Cell/immunology , Leukemia, Myelogenous, Chronic, BCR-ABL Positive/immunology , Leukemia, Myeloid, Acute/immunology , Leukemia, Prolymphocytic, T-Cell/immunology , Leukemia-Lymphoma, Adult T-Cell/immunology , Lymphoma, Non-Hodgkin/immunology
15.
Ann Med Interne (Paris) ; 139(5): 336-40, 1988.
Article in French | MEDLINE | ID: mdl-3202533

ABSTRACT

Large cell granulocytic leukemia (LCGL) or proliferative lymphocyte T gamma disease, characterized cytologically by the presence of lymphocytes with intracytoplasmic azurophil granules, raises the problem of whether or not it is monoclonal in character. However, although it may resemble a chronic lymphoid T leukemia or Felty's syndrome, it differs by the constant finding of infiltration of the splenic red pulp by large granular lymphocytes. Studies of their immunologic phenotype and functional activity produce heterogeneous results. The disease course varies considerably: the serious nature of the infections, knowledge of the physiopathologic mechanism of the neutropenia and the importance of the tumoral syndrome could represent therapeutic indications the modalities of which have still to be defined.


Subject(s)
Leukemia, Myeloid/pathology , Lymphocytes/pathology , Adult , Diagnosis, Differential , Felty Syndrome/pathology , Female , Humans , Leukemia, Lymphocytic, Chronic, B-Cell/pathology , Leukemia, Myeloid/immunology , Leukocyte Count , Lymphocytosis/immunology , Lymphocytosis/pathology , Middle Aged , Phenotype , Spleen/pathology
16.
Pathol Biol (Paris) ; 34(6): 753-7, 1986 Jun.
Article in French | MEDLINE | ID: mdl-3531991

ABSTRACT

The study of class I and class II antigen expression on leukemic cells brought the following conclusions: most of the leukemic cells show a slower number of class I antigenic sites than normal peripheral blood lymphocytes (PBL) but, in most cases, this does not hinder HLA typing; contrarily to normal PBL, leukemic cells seem to carry "non HLA" antigens (and/or non classical HLA antigens) which are probably responsible of the false positive reactions frequently observed at the time of HLA typing; most of the leukemic cell types express DR antigens (except those belonging to the T lineage) but DQ antigen expression (and in some cases MT antigen expression) varies depending on the cell type studied: well defined on mature B hemopathies, DQ expression is often lower than DR expression on acute leukemic cell types.


Subject(s)
HLA Antigens/genetics , HLA-D Antigens/genetics , Leukemia/genetics , HLA Antigens/analysis , HLA-D Antigens/analysis , HLA-DR Antigens/analysis , Humans , Leukemia/immunology
17.
Poumon Coeur ; 39(6): 283-6, 1983.
Article in French | MEDLINE | ID: mdl-6664943

ABSTRACT

The various studies which have dealt up to the present with a possible relationship between asbestosis and HLA groups have led to differing conclusions. The present study evaluated this relationship by comparison of 57 workers with asbestosis confirmed radiologically (minimum S1 type opacities) and functionally (VC and/or DuaCO less than 88%) with 58 controls from the same population. In a second phase, statistical analysis involved the combination of these cases with those reported in the literature, estimating the mean relative risk and, for each gene, the heterogeneity of the results thus collected. No relation was found between class I (A and B) HLA antigens and asbestosis. The authors suggest extension of this study to class II (DR) and III (components of complement) antigens and to seek possible links between combinations of antigens and the development of asbestosis.


Subject(s)
Asbestosis/immunology , HLA Antigens/analysis , Adult , Aged , Female , Humans , Male , Middle Aged , Risk , Statistics as Topic , Time Factors
SELECTION OF CITATIONS
SEARCH DETAIL
...